16 November 2020 Step up for TB 2020 - Social Media Gallery, Animated Images Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Blog Blog | 02 September 2021 COVID-19 When big pharma has all the power, what choice do countries like South Korea have? Issue brief Issue brief | 01 September 2021 Tuberculosis Realizing Returns on U.S. Government Investments in GeneXpert Diagnostic Technologies Photograph by Oksana Parafeniuk Research article Research article | 31 August 2021 Tuberculosis PLOS ONE: Public investments in the development of GeneXpert molecular diagnostic technology 2 min Technical brief | 27 August 2021 COVID-19 Sharing mRNA vaccine technologies to save lives Press release Press release | 23 August 2021 COVID-19 United States of America Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply Photo by Matthew Smeal Opinion article Opinion article | 20 August 2021 Tropical & neglected diseases BMJ Global Health: Control of visceral leishmaniasis in East Africa: fragile progress, new threats 3 min Letter | 09 August 2021 Hepatitis C Open letter to AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C Photograph by Mariana Abdalla Press release Press release | 26 July 2021 COVID-19 Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO 6 min Load More
Blog Blog | 02 September 2021 COVID-19 When big pharma has all the power, what choice do countries like South Korea have?
Issue brief Issue brief | 01 September 2021 Tuberculosis Realizing Returns on U.S. Government Investments in GeneXpert Diagnostic Technologies
Photograph by Oksana Parafeniuk Research article Research article | 31 August 2021 Tuberculosis PLOS ONE: Public investments in the development of GeneXpert molecular diagnostic technology 2 min
Press release Press release | 23 August 2021 COVID-19 United States of America Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply
Photo by Matthew Smeal Opinion article Opinion article | 20 August 2021 Tropical & neglected diseases BMJ Global Health: Control of visceral leishmaniasis in East Africa: fragile progress, new threats 3 min
Letter | 09 August 2021 Hepatitis C Open letter to AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C
Photograph by Mariana Abdalla Press release Press release | 26 July 2021 COVID-19 Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO 6 min